3-T MR-guided focused ultrasound thalamotomy for tremor in patients with a cardiac pacemaker: case series and review of the literature

MR-guided focused ultrasound (MRgFUS) has proven its efficacy and safety for the treatment of essential tremor (ET) and/or Parkinson's disease (PD). However, having a cardiac pacemaker has been considered an exclusion criterion for the use of MRgFUS. Only 2 patients with a cardiac pacemaker tre...

Full description

Saved in:
Bibliographic Details
Published in:Neurosurgical focus Vol. 57; no. 3; p. E5
Main Authors: Gonzalez-Quarante, Lain H, Gonzalez-Crespo, Antonio, Arcadi, Alana, Macias-de-la-Corte, Marta, Aviles-Olmos, Iciar, Sanchez-Catasus, Carlos A, Cacho-Asenjo, Elena, Honorato-Cia, Cristina, Martinez-Simon, Antonio, Gorospe, Arantza, Martin-Bastida, Antonio, Corral-Alonso, Paula, Rodriguez-Oroz, Maria C, Guridi, Jorge
Format: Journal Article
Language:English
Published: United States 01-09-2024
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:MR-guided focused ultrasound (MRgFUS) has proven its efficacy and safety for the treatment of essential tremor (ET) and/or Parkinson's disease (PD). However, having a cardiac pacemaker has been considered an exclusion criterion for the use of MRgFUS. Only 2 patients with a cardiac pacemaker treated with MRgFUS have been previously reported, both treated using 1.5-T MRI. In this paper, the authors present their experience performing 3-T MRgFUS thalamotomy in 4 patients with an implanted cardiac pacemaker. Treatments were uneventful regarding complications or severe side effects. MRgFUS using 3-T MRI was found to be an efficient and safe treatment for ET and/or PD in patients with an MRI-compatible pacemaker.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Review-5
content type line 23
ObjectType-Case Study-4
ObjectType-Feature-2
ObjectType-Report-3
ISSN:1092-0684
1092-0684
DOI:10.3171/2024.6.FOCUS24171